Aesthetic Stock Today

AIH
 Stock
  

USD 2.35  0.10  4.44%   

Market Performance
11 of 100
Odds Of Distress
Less than 40
Aesthetic Medical is trading at 2.35 as of the 7th of August 2022. This is a 4.44 percent increase since the beginning of the trading day. The stock's open price was 2.25. Aesthetic Medical has about a 40 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. Equity ratings for Aesthetic Medical International are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of July 2022 and ending today, the 7th of August 2022. Please note, there could be an existing legal relationship between Aesthetic Medical (AIH) and ABLEST INC (AIH1). Click here to learn more.
CUSIP
00371W100
Fiscal Year End
December
Business Domain
Health Care Equipment & Services
IPO Date
25th of October 2019
Category
Healthcare
Classification
Health Care
ISIN
US00809M1045
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the Peoples Republic of China. Aesthetic Medical operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. The company has 23.6 M outstanding shares of which 84.78 K shares are presently shorted by investors with about 4.55 days to cover. More on Aesthetic Medical International

Aesthetic Medical Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Aesthetic Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aesthetic Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Aesthetic Medical generated a negative expected return over the last 90 days
Aesthetic Medical has high historical volatility and very poor performance
The company has 413.05 M in debt with debt to equity (D/E) ratio of 4.2, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Aesthetic Medical has a current ratio of 0.18, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Aesthetic Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Aesthetic Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aesthetic Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aesthetic to invest in growth at high rates of return. When we think about Aesthetic Medical's use of debt, we should always consider it together with cash and equity.
The entity reported the last year's revenue of 671.09 M. Reported Net Loss for the year was (503.14 M) with profit before taxes, overhead, and interest of 269.5 M.
Aesthetic Medical International has about 31.01 M in cash with (843 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44.
Latest headline from www.globenewswire.com: Asia Pacific Latin America to Exhibit High Demand Growth for Medical Equipment Cooling Systems Fact.MR Analysis - GlobeNewswire
Related EntityAIH1 (ABLEST INC)
Thematic IdeaHealthcare (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Aesthetic Medical report their recommendations after researching Aesthetic Medical's financial statements, talking to executives and customers, or listening in on Aesthetic Medical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Aesthetic Medical. The Aesthetic consensus assessment is calculated by taking the average forecast from all of the analysts covering Aesthetic Medical.
Strong Buy1 Opinion
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Aesthetic Medical based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Aesthetic Medical financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares67.1 M70.8 M
Notably Down
Decreasing
Slightly volatile
Net Cash Flow from Operations51.3 M51.7 M
Slightly Down
Decreasing
Stable
Total Assets757.2 M576.9 M
Significantly Up
Increasing
Slightly volatile
Total Liabilities790.6 M763.4 M
Sufficiently Up
Increasing
Slightly volatile
Current Assets151.3 M113.7 M
Significantly Up
Decreasing
Slightly volatile
Current Liabilities448.3 M541.7 M
Significantly Down
Increasing
Slightly volatile
Total Debt421.9 M405.9 M
Sufficiently Up
Increasing
Slightly volatile
Return on Average Assets(0.75)(0.726)
Sufficiently Down
Decreasing
Very volatile
Gross Margin0.480.417
Fairly Up
Decreasing
Slightly volatile
Asset Turnover0.830.799
Sufficiently Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Aesthetic Medical's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellUndervalued
Financial Strength
Aesthetic Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aesthetic Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aesthetic Medical's financial leverage. It provides some insight into what part of Aesthetic Medical's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Aesthetic Medical's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Aesthetic Medical deploys its capital and how much of that capital is borrowed.
Liquidity
Aesthetic Medical cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 413.05 M in debt with debt to equity (D/E) ratio of 4.2, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Aesthetic Medical has a current ratio of 0.18, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist Aesthetic Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Aesthetic Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aesthetic Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aesthetic to invest in growth at high rates of return. When we think about Aesthetic Medical's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

51.31 Million
Aesthetic Medical International (AIH) is traded on NASDAQ Exchange in USA. It is located in 1122 Nanshan Boulevard and employs 1,451 people. Aesthetic Medical is listed under Healthcare category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with total capitalization of 56.63 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aesthetic Medical's market, we take the total number of its shares issued and multiply it by Aesthetic Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Aesthetic Medical runs under Healthcare sector within Medical Care Facilities industry. The entity has 23.6 M outstanding shares of which 84.78 K shares are presently shorted by investors with about 4.55 days to cover. Aesthetic Medical International has about 31.01 M in cash with (843 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44.
Check Aesthetic Medical Probability Of Bankruptcy
Ownership
Aesthetic Medical retains a total of 23.6 Million outstanding shares. Almost 98.0 percent of Aesthetic Medical outstanding shares are held by regular investors with 0.0 (percent) owned by insiders and only 2.28 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Aesthetic Ownership Details

Aesthetic Stock Price Odds Analysis

What are Aesthetic Medical's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Aesthetic Medical jumping above the current price in 90 days from now is about 31.79%. The Aesthetic Medical International probability density function shows the probability of Aesthetic Medical stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Aesthetic Medical International has a beta of -0.4452. This suggests as returns on benchmark increase, returns on holding Aesthetic Medical are expected to decrease at a much lower rate. During the bear market, however, Aesthetic Medical International is likely to outperform the market. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Aesthetic Medical is significantly underperforming DOW.
  Odds Below 2.35HorizonTargetOdds Above 2.35
68.06%90 days
 2.35 
31.79%
Based on a normal probability distribution, the odds of Aesthetic Medical to move above the current price in 90 days from now is about 31.79 (This Aesthetic Medical International probability density function shows the probability of Aesthetic Stock to fall within a particular range of prices over 90 days) .

Aesthetic Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Aesthetic Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Aesthetic Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aesthetic Medical's value.
InstituionSecurity TypeTotal SharesValue
Idg Technology Venture Investment Iv LlcCommon Shares396.1 K844 K
Idg Technology Venture Investment Iv LlcCommon Shares396.1 K642 K
View Aesthetic Medical Diagnostics

Aesthetic Medical Historical Income Statement

Aesthetic Medical International Income Statement is one of the three primary financial statements used for reporting Aesthetic's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Aesthetic Medical revenue and expense. Aesthetic Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Aesthetic Medical Selling General and Administrative Expense is most likely to increase significantly in the upcoming years. The last year's value of Selling General and Administrative Expense was reported at 611.65 Million View More Fundamentals

Aesthetic Stock Against Markets

Picking the right benchmark for Aesthetic Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Aesthetic Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Aesthetic Medical is critical whether you are bullish or bearish towards Aesthetic Medical International at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aesthetic Medical without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Invested in Aesthetic Medical International?

You need to understand the risk of investing before taking a position in Aesthetic Medical. The danger of trading Aesthetic Medical International is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aesthetic Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aesthetic Medical. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aesthetic Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Aesthetic Medical information on this page should be used as a complementary analysis to other Aesthetic Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Aesthetic Stock analysis

When running Aesthetic Medical price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Is Aesthetic Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aesthetic Medical. If investors know Aesthetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aesthetic Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
12.19
Market Capitalization
72.2 M
Quarterly Revenue Growth YOY
0.19
Return On Assets
-0.2
Return On Equity
-4.92
The market value of Aesthetic Medical is measured differently than its book value, which is the value of Aesthetic that is recorded on the company's balance sheet. Investors also form their own opinion of Aesthetic Medical's value that differs from its market value or its book value, called intrinsic value, which is Aesthetic Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aesthetic Medical's market value can be influenced by many factors that don't directly affect Aesthetic Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aesthetic Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Aesthetic Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aesthetic Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.